Downloads

  1. Charting The Future Of Antimicrobial Resistance 1/21/2026

    We caught up with Ajit Parhi, Ph.D., CSO of TAXIS Pharmaceuticals, to discuss policy, precision science, and AI in battling antimicrobial resistance.

  2. Advanced Automation System For Flexible Aseptic Filling 1/14/2026

    Discover a gloveless system designed to provide an optimal aseptic process with a standardized flexible filler capable of producing vials, syringes and cartridges.

  3. Closed Robotic Isolator For Reduced Risk And Flexibility In Vial Filling 1/14/2026

    Ensure your manufacturing projects run smoothly no matter whatever comes down your pipeline. Discover a fully automated, closed robotic isolator for reduced risk and flexibility in pharmaceutical vial filling.

  4. Flexibility First: A Fill And Finish Collaboration Story 1/7/2026

    Learn how Annex 1 is influencing isolator strategies, why standardization is key to efficiency, and how collaboration can simplify integration for reliable drug product filling.

  5. Commercial-Scale, Single-Use Tangential Flow Filtration System 1/7/2026

    Achieve efficient, automated filtration for biopharmaceutical production with a system offering high throughput that is designed for ultrafiltration, diafiltration, and microfiltration.

  6. Compliance In Conversation: A Fill And Finish Regulatory Roundtable 1/7/2026

    Explore Annex 1 expectations, PFAS legislation, and contamination control strategies in this expert-led discussion, as well as practical insights on risk mitigation, validation, and inspection readiness.

  7. Boost Process Efficiency With Our New mAb Optimized TFF Cassette 1/7/2026

    Discover how optimized membranes and screen designs enable higher mAb concentrations, improved flux performance, and scalability, while addressing TFF process challenges.

  8. Efficient Purification Of Diverse Single Domain Antibodies 1/7/2026

    Discover how mixed-mode chromatography enables high-yield purification of single-domain antibodies under mild conditions and why these approaches outperform traditional resins.

  9. The FXI Gamble: To Bleed Less... Or To Protect Less? 1/2/2026

    A new generation of FXI and FXIa inhibitors is stepping in with bold promises to reduce bleeding while preserving direct oral anticoagulant-like efficacy. Is this the start of a new era?

  10. Hibernating Squirrels May Hold Clues To Treating Heart Failure 1/2/2026

    Examining natural mechanisms of cardiac repair in hibernating squirrels has provided insight into biological pathways that could help develop a therapeutic for HFpEF.